These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 11156851)
1. Enhanced superoxide production in experimental venous bypass graft intimal hyperplasia: role of NAD(P)H oxidase. West N; Guzik T; Black E; Channon K Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):189-94. PubMed ID: 11156851 [TBL] [Abstract][Full Text] [Related]
2. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production. Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127 [TBL] [Abstract][Full Text] [Related]
4. c-Jun regulates shear- and injury-inducible Egr-1 expression, vein graft stenosis after autologous end-to-side transplantation in rabbits, and intimal hyperplasia in human saphenous veins. Ni J; Waldman A; Khachigian LM J Biol Chem; 2010 Feb; 285(6):4038-4048. PubMed ID: 19940138 [TBL] [Abstract][Full Text] [Related]
5. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment. el-Sanadiki MN; Cross KS; Murray JJ; Schuman RW; Mikat E; McCann RL; Hagen PO Ann Surg; 1990 Jul; 212(1):87-96. PubMed ID: 2363608 [TBL] [Abstract][Full Text] [Related]
6. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure. Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670 [TBL] [Abstract][Full Text] [Related]
8. Time course of the regression of intimal hyperplasia in experimental vein grafts. Davies MG; Fulton GJ; Svendsen E; Hagen PO Cardiovasc Pathol; 1999; 8(3):161-8. PubMed ID: 10722239 [TBL] [Abstract][Full Text] [Related]
9. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts. Zou J; Zhang X; Yang H; Zhu Y; Ma H; Wang S Ann Vasc Surg; 2011 May; 25(4):538-46. PubMed ID: 21549923 [TBL] [Abstract][Full Text] [Related]
10. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition. Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565 [TBL] [Abstract][Full Text] [Related]
12. [Local shRNA modulation of phosphatidylinositol 3-kinase signaling pathway reduces intimal hyperplasia in vein grafts: experiment with rats]. Deng YZ; Liu SJ; Ma L; Sun ZQ; Chen JJ; Su G; Liu C; Wang GH; Ke J Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1713-6. PubMed ID: 17825157 [TBL] [Abstract][Full Text] [Related]
13. Local treatment with recombinant tissue factor pathway inhibitor reduces the development of intimal hyperplasia in experimental vein grafts. Huynh TT; Davies MG; Thompson MA; Ezekowitz MD; Hagen P; Annex BH J Vasc Surg; 2001 Feb; 33(2):400-7. PubMed ID: 11174796 [TBL] [Abstract][Full Text] [Related]
14. Effect of external stenting and systemic hypertension on intimal hyperplasia in rat vein grafts. Meguro T; Nakashima H; Kawada S; Tokunaga K; Ohmoto T Neurosurgery; 2000 Apr; 46(4):963-9; discussion 969-70. PubMed ID: 10764272 [TBL] [Abstract][Full Text] [Related]